NEW: FDA's Julie Tierney and Dr. Nicole Verdun to Speak at ASGCT's Policy Summit (Sept. 23-24). Register Now!
Emily Walsh Martin, PhD, discusses pressing challenges currently facing CGT developers and clinicians.
Find insightful intervews, riviting conversations, and incredible discoveries on the ASGCT Podcast Network.
SalioGen CEO Jason Cole joins to explore the company's cutting-edge transposase-based gene insertion technology presented at the ASGCT 27th Annual Meeting.
"Geek out" with Susan and Emily on the intricacies of defining your CMC strategy and ready yourselves for a tour-de-force of analytical and process development for viral vectors.
Join Emily Walsh Martin, PhD for an in-depth interview with Sabrina Mogle, co-founder of RareMoon Consulting.
Dr. Mingozzi has done seminal work throughout his career in AAV gene therapy. Listen to him talk with Emily Walsh Martin, PhD, about his career and immunogenicity.
Tom McCauley, PhD (Omega Therapeutics) joins Emily Walsh Martin, PhD to explore the next generation of molecular therapeutics on the second episode of The Issue, available now on the ASGCT Podcast Network.
Michael Storey, PharmD (Nationwide Children's Hospital), and host Emily Walsh Martin, PhD, discuss the path from patient diagnosis to therapy administration for approved gene and cell therapies including the clinical and administrative steps along the way.
September 23-24, 2024 | Washington, D.C.
© 2000-2024 All rights reserved. American Society of Gene & Cell Therapy.
Kentico CMS Development by Reason One | Powered by Kentico